Kriya Therapeutics
CA - Redwood CityBiotechnology
Focus: Kriya Therapeutics is a gene therapy biotech focused on treating rare and serious diseases including thyroid eye disease, geographic atrophy, and trigeminal neuralgia. The company is in early-stage development with three Phase 1/2 programs and operates from Redwood City, California.
Profile data last refreshed 12h ago · AI intelligence enriched 2w ago
Funding Stage
SERIES C +
Total Funding
$900M
Open Jobs
6+2 this month
Stable — net +2 jobs in 30d
3 added, 1 removed. Backfill posture.
Should You Work at Kriya Therapeutics?
AI assessmentKriya is a high-risk, early-stage gene therapy bet suitable for scientists and clinicians seeking hands-on R&D ownership in an emerging field, but not for those seeking near-term revenue visibility or organizational stability.
Why Work Here
- Ground-floor opportunity at a Series C+ gene therapy company with three active clinical programs addressing high-unmet-need indications.
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
4 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
PHASE_1_2
Clinical Trials (1)
NCT06765980A Study to Evaluate KRIYA-825 (VV-14295) in Adults With Geographic Atrophy Secondary to Age-related Macular Degeneration
Phase 1/2Help build intelligence for Kriya Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.